Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 4—April 2015

Multidrug-Resistant Salmonella enterica Serotype Typhi, Gulf of Guinea Region, Africa

Murielle Baltazar12, Antoinette Ngandjio1, Kathryn Elizabeth Holt, Elodie Lepillet, Maria Pardos de la Gandara3, Jean-Marc Collard, Raymond Bercion4, Ariane Nzouankeu, Simon Le Hello, Gordon Dougan, Marie-Christine Fonkoua, and François-Xavier WeillComments to Author 
Author affiliations: Institut Pasteur, Paris, France (M. Baltazar, E. Lepillet, M. Pardos de la Gandara, S. Le Hello, F.-X. Weill); Centre Pasteur du Cameroun, Yaoundé, Cameroon (A. Ngandjio, A. Nzouankeu, M.-C. Fonkoua); University of Melbourne, Melbourne, Victoria, Australia (K.E. Holt); Wellcome Trust Sanger Institute, Cambridge, UK (K.E. Holt, G. Dougan); Scientific Institute of Public Health, Brussels, Belgium (J.-M. Collard); Institut Pasteur de Bangui, Bangui, Central African Republic (R. Bercion)

Main Article


Characteristics of Salmonella enterica serotype Typhi isolates, France and Cameroon, 1996–2013*

Location 1996–1999 2000–2004 2005–2009 2010–2013
No. isolates studied 345 266 627 508
No. isolates acquired in Africa 86 64 155 103
No. (%) MDR† 0 7 (10.9) 25 (16.1) 23 (22.3)
Country of infection for MDR isolates (no.) Benin (3), Togo (2), Burkina-Faso (1), Cameroon (1) Cameroon (7), Côte d’Ivoire (4), Burkina-Faso (3), Angola (2), Congo (1), Mali (1), Benin (1), Nigeria (1), Mauritania (1), Togo (1), Central African Republic (1), Guinea (1), not specified (1) Côte d’Ivoire (7), Guinea (3), Burkina-Faso (3), Cameroon (2), Congo (1), Central African Republic (1), Niger (1), Mali (1), Nigeria (1), Chad (1), Togo (1), Algeria (1)
Yaoundé, Cameroon
No. isolates studied ND 61 75 49
No. (%) MDR ND 29 (47.5) 50 (66.6) 37 (75.5)

*MDR, multidrug resistant; ND, not determined.
†For isolates acquired in Africa.

Main Article

1These authors contributed equally to this article.

2Current affiliation: University of Limoges, Limoges, France.

3Current affiliation: Rockefeller University, New York, New York, USA.

4Current affiliation: Institute Pasteur de Dakar, Dakar, Senegal.

Page created: March 17, 2015
Page updated: March 17, 2015
Page reviewed: March 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.